Green tea (-)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia

Behavioural Brain Research

Volumn 236, Issue 1, 2013, Pages 186-193

  Biasibetti, Regina ^a   Tramontina, Ana Carolina ^a   Costa, Ana Paula ^a   Dutra, Márcio Ferreira ^a   Quincozes Santos, André ^a   Nardin, Patrícia ^a   Bernardi, Caren Luciane ^a   Wartchow, Krista Minéia ^a   Lunardi, Paula Santana ^a   Gonçalves, Carlos Alberto ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Acetylcholinesterase; Astrocytes; Dementia; Epigallocatechin gallate; Oxidative stress; Streptozotocin

Indexed keywords

ACETYLCHOLINESTERASE; BIOLOGICAL MARKER; EPIGALLOCATECHIN GALLATE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; NITRIC OXIDE; PROTEIN S100B; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; GLUCOSE TRANSPORT; HIPPOCAMPUS; LATENT PERIOD; MALE; MAZE TEST; MENTAL PERFORMANCE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SECRETION; RAT; SHAM PROCEDURE; TEA; TREATMENT DURATION;

ACETYLCHOLINESTERASE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; CATECHIN; COGNITION; DEMENTIA; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; NERVE GROWTH FACTORS; NEUROGLIA; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; S100 PROTEINS; SPACE PERCEPTION; STREPTOZOCIN; TEA;

EID: 84866269044     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.08.039     Document Type: Article

References (54)

1. Ritchie K., Lovestone S. The dementias. Lancet 2002, 360:1759-1766.
2. Shagam J.Y. The many faces of dementia. Radiologic Technology 2009, 81:153-168.
3. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117.
4. Selkoe D.J. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. Journal of Alzheimer's Disease 2001, 3:75-80.
5. Baydas G., Nedzvetskii V.S., Nerush P.A., Kirichenko S.V., Yoldas T. Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocin-induced diabetes mellitus. Life Sciences 2003, 73:1907-1916.
6. Lannert H., Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behavioral Neuroscience 1998, 112:1199-1208.
7. Sharma M., Gupta Y.K. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sciences 2002, 71:2489-2498.
8. Duelli R., Schrock H., Kuschinsky W., Hoyer S. Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. International Journal of Developmental Neuroscience 1994, 12:737-743.
9. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiology of Aging 2005, 26:349-354.
10. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., et al. S100B's double life: intracellular regulator and extracellular signal. Biochimica et Biophysica Acta 2009, 1793:1008-1022.
11. Goncalves C.A., Leite M.C., Nardin P. Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clinical Biochemistry 2008, 41:755-763.
12. Doss M.X., Potta S.P., Hescheler J., Sachinidis A. Trapping of growth factors by catechins: a possible therapeutical target for prevention of proliferative diseases. The Journal of Nutritional Biochemistry 2005, 16:259-266.
13. Weinreb O., Amit T., Mandel S., Youdim M.B. Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes & Nutrition 2009, 4:283-296. 10.1007/s12263-009-0143-4.
14. Yao K., Ye P., Zhang L., Tan J., Tang X., Zhang Y. Epigallocatechin gallate protects against oxidative stress-induced mitochondria-dependent apoptosis in human lens epithelial cells. Molecular Vision 2008, 14:217-223.
15. Tramontina A.C., Wartchow K.M., Rodrigues L., Biasibetti R., Quincozes-Santos A., Bobermin L., et al. The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats. Journal of Neural Transmission 2011, 118:1641-1649.
16. Devika P.T., Stanely Mainzen P.P. Protective effect of (-)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: a histopathological study. Biomedicine and Pharmacotherapy 2008, 62:701-708.
17. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 1984, 11:47-60.
18. Rodrigues L., Dutra M.F., Ilha J., Biasibetti R., Quincozes-Santos A., Leite M.C., et al. Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin. Journal of Neural Transmission 2010, 117:1295-1305.
19. Silva M.C., Rocha J., Pires C.S., Ribeiro L.C., Brolese G., Leite M.C., et al. Transitory gliosis in the CA3 hippocampal region in rats fed on a ketogenic diet. Nutritional Neuroscience 2005, 8:259-264.
20. Leite M.C., Galland F., Brolese G., Guerra M.C., Bortolotto J.W., Freitas R., et al. A simple, sensitive and widely applicable ELISA for S100B: methodological features of the measurement of this glial protein. Journal of Neuroscience Methods 2008, 169:93-99.
21. Tramontina F., Leite M.C., Cereser K., de Souza D.F., Tramontina A.C., Nardin P., et al. Immunoassay for glial fibrillary acidic protein: antigen recognition is affected by its phosphorylation state. Journal of Neuroscience Methods 2007, 162:282-286.
22. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 1961, 7:88-95.
23. Browne R.W., Armstrong D. Reduced glutathione and glutathione disulfide. Methods in Molecular Biology 1998, 108:347-352.
24. Hevel J.M., Marletta M.A. Nitric-oxide synthase assays. Methods in Enzymology 1994, 233:250-258.
25. Vieira de Almeida L.M., Pineiro C.C., Leite M.C., Brolese G., Leal R.B., Gottfried C., et al. Protective effects of resveratrol on hydrogen peroxide induced toxicity in primary cortical astrocyte cultures. Neurochemical Research 2008, 33:8-15.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
27. Rodrigues L., Biasibetti R., Swarowsky A., Leite M.C., Quincozes-Santos A., Quilfeldt J.A., et al. Hippocampal alterations in rats submitted to streptozotocin-induced dementia model are prevented by aminoguanidine. Journal of Alzheimer's Disease 2009, 17:193-202.
28. Saxena G., Singh S.P., Agrawal R., Nath C. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. European Journal of Pharmacology 2008, 581:283-289.
29. Salkovic-Petrisic M., Hoyer S. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. Journal of Neural Transmission Supplementum 2007, 21:7-33.
30. Sharma M., Gupta Y.K. Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats. Pharmacology Biochemistry and Behavior 2001, 70:325-331.
31. Hsuuw Y.D., Chan W.H. Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells. Annals of the New York Academy of Sciences 2007, 1095:428-440.
32. Chung W.G., Miranda C.L., Maier C.S. Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells. Brain Research 2007, 1176:133-142.
33. Javed H., Khan M.M., Khan A., Vaibhav K., Ahmad A., Khuwaja G., et al. S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Research 2011, 1389:133-142.
34. Tiwari V., Kuhad A., Bishnoi M., Chopra K. Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats. Pharmacology Biochemistry and Behavior 2009, 93:183-189.
35. Lin Y.L., Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Molecular Pharmacology 1997, 52:465-472.
36. Nagai K., Jiang M.H., Hada J., Nagata T., Yajima Y., Yamamoto S., et al. (-)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant. Brain Research 2002, 956:319-322.
37. Ellis J.M. Cholinesterase inhibitors in the treatment of dementia. Journal of the American Osteopathic Association 2005, 105:145-158.
38. Fernandez-Bachiller M.I., Perez C., Gonzalez-Munoz G.C., Conde S., Lopez M.G., Villarroya M., et al. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties. Journal of Medicinal Chemistry 2010, 53:4927-4937.
39. Hoyer S., Lannert H. Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein. Journal of Neural Transmission Supplementum 2007, 19:5-202.
40. Norris C.M., Kadish I., Blalock E.M., Chen K.C., Thibault V., Porter N.M., et al. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. Journal of Neuroscience 2005, 25:4649-4658.
41. Leal R.B., Frizzo J.K., Tramontina F., Fieuw-Makaroff S., Bobrovskaya L., Dunkley P.R., et al. S100B protein stimulates calcineurin activity. Neuroreport 2004, 15:317-320.
42. Swarowsky A., Rodrigues L., Biasibetti R., Leite M.C., de Oliveira L.F., de Almeida L.M., et al. Glial alterations in the hippocampus of rats submitted to ibotenic-induced lesion of the nucleus basalis magnocellularis. Behavioural Brain Research 2008, 190:206-211.
43. Vicente E., Degerone D., Bohn L., Scornavaca F., Pimentel A., Leite M.C., et al. Astroglial and cognitive effects of chronic cerebral hypoperfusion in the rat. Brain Research 2009, 1251:204-212.
44. Javed H., Khan M.M., Ahmad A., Vaibhav K., Ahmad M.E., Khan A., et al. Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience 2012, 210:340-352.
45. Peskind E.R., Griffin W.S., Akama K.T., Raskind M.A., Van Eldik L.J. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochemistry International 2001, 39:409-413.
46. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. International Journal of Biochemistry and Cell Biology 2001, 33:637-668.
47. Costa A.P., Tramontina A.C., Biasibetti R., Batassini C., Lopes M.W., Wartchow K.M., et al. Neuroglial alterations in rats submitted to the okadaic acid-induced model of dementia. Behavioural Brain Research 2011.
48. Katiyar S.K., Mukhtar H. Tea antioxidants in cancer chemoprevention. Journal of Cellular Biochemistry. Supplement 1997, 27:59-67.
49. Rezai-Zadeh K., Arendash G.W., Hou H., Fernandez F., Jensen M., Runfeldt M., et al. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Research 2008, 1214:177-187.
50. de Souza D.F., Leite M.C., Quincozes-Santos A., Nardin P., Tortorelli L.S., Rigo M.M., et al. S100B secretion is stimulated by IL-1beta in glial cultures and hippocampal slices of rats: likely involvement of MAPK pathway. Journal of Neuroimmunology 2009, 206:52-57.
51. Singh B.N., Shankar S., Srivastava R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemical Pharmacology 2011, 82:1807-1821.
52. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 2001, 22:153-183.
53. El Omri A., Han J., Yamada P., Kawada K., Ben Abdrabbah M., Isoda H. Rosmarinus officinalis polyphenols activate cholinergic activities in PC12 cells through phosphorylation of ERK1/2. Journal of Ethnopharmacology 2010, 131:451-458.
54. Wolf C., Rothermel A., Robitzki A.A. Neurturin, a member of the glial cell line-derived neurotrophic factor family, affects the development of acetylcholinesterase-positive cells in a three-dimensional model system of retinogenesis. Journal of Neurochemistry 2008, 107:96-104.